Clinical trials
Phase 3 COVID-19 trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
38 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2015 | 1 |
| 2016 | 1 |
| 2018 | 1 |
| 2020 | 15 |
| 2021 | 11 |
| 2022 | 3 |
| 2023 | 2 |
| 2024 | 1 |
| 2025 | 1 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 15 |
| Terminated | 10 |
| Recruiting | 5 |
| Unknown status | 4 |
| Active, not recruiting | 2 |
| Not yet recruiting | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| McGill University Health Centre/Research Institute of the McGill University Health Centre | 3 |
| Unity Health Toronto | 3 |
| Ottawa Heart Institute Research Corporation | 2 |
| Sunnybrook Health Sciences Centre | 2 |
| University Health Network, Toronto | 2 |
| Université de Sherbrooke | 2 |
| AstraZeneca | 1 |
| Atea Pharmaceuticals, Inc. | 1 |
| Canadian Cancer Trials Group | 1 |
| Corvus Pharmaceuticals, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| COVID-19 | 38 |
| Coronavirus Infections | 12 |
| Severe Acute Respiratory Syndrome | 5 |
| Respiratory Tract Infections | 4 |
| Influenza, Human | 3 |
| Lung Diseases | 3 |
| Respiratory Distress Syndrome | 3 |
| Virus Diseases | 3 |
| Cardiovascular Diseases | 2 |
| Infections | 2 |
Trials
Showing 1 to 25 of 38. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.